News & Perspective

Nov 10, 2016

Nov 10, 2016
cystic fibrosis

Study describes spread of drug-resistant bug that infects cystic fibrosis patients

The bacterium may have recently evolved to spread person to person, as it becomes more virulent.

Aug 09, 2016

Aug 09, 2016

News Scan for Aug 09, 2016

Aerosol stability in Ebola
HIV and drug-resistant TB
Global flu status
Campylobacter infection in children
Chikungunya update

Jun 28, 2016

Jun 28, 2016

News Scan for Jun 28, 2016

Saudi MERS cases
2009 H1N1 origins in Mexico
WHO health emergency head
Strategic National Stockpile report

Nov 12, 2015

Nov 12, 2015
Nurse Pauline Cafferkey

UK nurse with Ebola meningitis released from isolation

Also, researchers note vaccine storage limitations, and Australia eases screening.

Mar 03, 2015

Mar 03, 2015

News Scan for Mar 03, 2015

Another MERS case
HPV vaccine benefits

Oct 27, 2014

Oct 27, 2014

CSL-Novartis deal includes US cell-based flu vaccine plant

The $275 million deal will make the company the second leading player in the $4 billion global flu vaccine market.

Feb 14, 2013

Feb 14, 2013

Euro studies show flu vaccine working best against type B

(CIDRAP News) – New European studies reported today in Eurosurveillance suggest that this year's influenza vaccine is providing good protection against influenza B viruses but only moderate protection against type A—findings more or less consistent with earlier results in the United States.

Jan 24, 2013

Jan 24, 2013

CDC: New norovirus strain fueling US outbreaks

(CIDRAP News) – A new norovirus variant that emerged in Australia last year has been the leading cause of norovirus outbreaks in United States over the past few months, and federal health officials today warned that illnesses could increase in the months ahead.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»